Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does KETOROLAC TROMETHAMINE Cause Hyperhidrosis? 353 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 353 reports of Hyperhidrosis have been filed in association with KETOROLAC TROMETHAMINE (ketorolac tromethamine). This represents 5.7% of all adverse event reports for KETOROLAC TROMETHAMINE.

353
Reports of Hyperhidrosis with KETOROLAC TROMETHAMINE
5.7%
of all KETOROLAC TROMETHAMINE reports
0
Deaths
24
Hospitalizations

How Dangerous Is Hyperhidrosis From KETOROLAC TROMETHAMINE?

Of the 353 reports, 24 (6.8%) required hospitalization, and 3 (0.8%) were considered life-threatening.

Is Hyperhidrosis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for KETOROLAC TROMETHAMINE. However, 353 reports have been filed with the FAERS database.

What Other Side Effects Does KETOROLAC TROMETHAMINE Cause?

Drug ineffective (1,172) Drug hypersensitivity (838) Treatment failure (776) Off label use (593) Nausea (501) Product use in unapproved indication (328) Nightmare (325) Sedation (319) Dyspnoea (244) Nephrolithiasis (234)

What Other Drugs Cause Hyperhidrosis?

DULOXETINE (4,101) ADALIMUMAB (2,745) SODIUM (2,444) VENLAFAXINE (1,932) LEVOTHYROXINE (1,856) ACETAMINOPHEN (1,578) ETANERCEPT (1,521) MORPHINE (1,438) GABAPENTIN (1,408) PREGABALIN (1,385)

Which KETOROLAC TROMETHAMINE Alternatives Have Lower Hyperhidrosis Risk?

KETOROLAC TROMETHAMINE vs KETOROLAC\KETOROLAC TROMETHAMINE KETOROLAC TROMETHAMINE vs KETOTIFEN KETOROLAC TROMETHAMINE vs KLONOPIN KETOROLAC TROMETHAMINE vs L-ASPARAGINASE KETOROLAC TROMETHAMINE vs LABETALOL

Related Pages

KETOROLAC TROMETHAMINE Full Profile All Hyperhidrosis Reports All Drugs Causing Hyperhidrosis KETOROLAC TROMETHAMINE Demographics